Your browser doesn't support javascript.
loading
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.
Rinaldetti, Sébastien; Zhou, Qiong; Abbott, Joshua M; de Jong, Florus C; Esquer, Hector; Costello, James C; Theodorescu, Dan; LaBarbera, Daniel V.
Afiliación
  • Rinaldetti S; The Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Zhou Q; The Department of Hematology-Oncology, Centre Hospitalier de Luxembourg, 1210 Luxembourg, Luxembourg.
  • Abbott JM; The Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • de Jong FC; The Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Esquer H; The Department of Urology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
  • Costello JC; The Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Theodorescu D; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • LaBarbera DV; The University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Int J Mol Sci ; 23(18)2022 Sep 14.
Article en En | MEDLINE | ID: mdl-36142576

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos